Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6479232rdf:typepubmed:Citationlld:pubmed
pubmed-article:6479232lifeskim:mentionsumls-concept:C0030847lld:lifeskim
pubmed-article:6479232lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:6479232lifeskim:mentionsumls-concept:C0013030lld:lifeskim
pubmed-article:6479232lifeskim:mentionsumls-concept:C0206128lld:lifeskim
pubmed-article:6479232lifeskim:mentionsumls-concept:C0039082lld:lifeskim
pubmed-article:6479232lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:6479232pubmed:issue1-2lld:pubmed
pubmed-article:6479232pubmed:dateCreated1984-11-20lld:pubmed
pubmed-article:6479232pubmed:abstractTextThe efficacy of several drugs to elicit yawning and penile erections were determined in rats. The dopamine agonists, N-propylnorapomorphine, apomorphine, pergolide, (+/-)-3-PPP, TL-99 and N,N-dipropylamino-5,6-dihydroxy-1,2,3,4-tetrahydronaphthalene (N,N-dipropyl A-5,6-DTN) all elicited yawning accompanied by an increase in spontaneous penile erections. The potencies of these drugs in causing yawning closely resemble published data concerning their actions in biochemical tests reputedly indicative of autoreceptor activity. In contrast, SK&F 38393, A-5,6-DTN and clonidine produced no yawning and few or no penile erections. Although physostigmine also caused yawning, the effect was not accompanied by penile erections. Studies with the optical isomers of 3-PPP showed that (+)-3-PPP was considerably more potent than (-)-3-PPP. Haloperidol antagonised dopamine agonist-induced yawning and penile erections. Apomorphine-induced yawning and penile erections were also antagonised by sulpiride and atropine but not by domperidone. The suitability of elicitation of the combined syndrome of yawning plus penile erections as useful behavioural model for dopamine autoreceptor agonists is discussed.lld:pubmed
pubmed-article:6479232pubmed:languageenglld:pubmed
pubmed-article:6479232pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6479232pubmed:citationSubsetIMlld:pubmed
pubmed-article:6479232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6479232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6479232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6479232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6479232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6479232pubmed:statusMEDLINElld:pubmed
pubmed-article:6479232pubmed:monthAuglld:pubmed
pubmed-article:6479232pubmed:issn0014-2999lld:pubmed
pubmed-article:6479232pubmed:authorpubmed-author:GowerA JAJlld:pubmed
pubmed-article:6479232pubmed:authorpubmed-author:BroekkampC...lld:pubmed
pubmed-article:6479232pubmed:authorpubmed-author:PrincenM MMMlld:pubmed
pubmed-article:6479232pubmed:authorpubmed-author:BerendsenH...lld:pubmed
pubmed-article:6479232pubmed:issnTypePrintlld:pubmed
pubmed-article:6479232pubmed:day3lld:pubmed
pubmed-article:6479232pubmed:volume103lld:pubmed
pubmed-article:6479232pubmed:ownerNLMlld:pubmed
pubmed-article:6479232pubmed:authorsCompleteYlld:pubmed
pubmed-article:6479232pubmed:pagination81-9lld:pubmed
pubmed-article:6479232pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6479232pubmed:meshHeadingpubmed-meshheading:6479232-...lld:pubmed
pubmed-article:6479232pubmed:meshHeadingpubmed-meshheading:6479232-...lld:pubmed
pubmed-article:6479232pubmed:meshHeadingpubmed-meshheading:6479232-...lld:pubmed
pubmed-article:6479232pubmed:meshHeadingpubmed-meshheading:6479232-...lld:pubmed
pubmed-article:6479232pubmed:meshHeadingpubmed-meshheading:6479232-...lld:pubmed
pubmed-article:6479232pubmed:meshHeadingpubmed-meshheading:6479232-...lld:pubmed
pubmed-article:6479232pubmed:meshHeadingpubmed-meshheading:6479232-...lld:pubmed
pubmed-article:6479232pubmed:meshHeadingpubmed-meshheading:6479232-...lld:pubmed
pubmed-article:6479232pubmed:meshHeadingpubmed-meshheading:6479232-...lld:pubmed
pubmed-article:6479232pubmed:meshHeadingpubmed-meshheading:6479232-...lld:pubmed
pubmed-article:6479232pubmed:meshHeadingpubmed-meshheading:6479232-...lld:pubmed
pubmed-article:6479232pubmed:meshHeadingpubmed-meshheading:6479232-...lld:pubmed
pubmed-article:6479232pubmed:meshHeadingpubmed-meshheading:6479232-...lld:pubmed
pubmed-article:6479232pubmed:meshHeadingpubmed-meshheading:6479232-...lld:pubmed
pubmed-article:6479232pubmed:meshHeadingpubmed-meshheading:6479232-...lld:pubmed
pubmed-article:6479232pubmed:meshHeadingpubmed-meshheading:6479232-...lld:pubmed
pubmed-article:6479232pubmed:year1984lld:pubmed
pubmed-article:6479232pubmed:articleTitleThe yawning-penile erection syndrome as a model for putative dopamine autoreceptor activity.lld:pubmed
pubmed-article:6479232pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6479232lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6479232lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6479232lld:pubmed